5-oxoprolinase deficiency is a rare genetic condition that affects how the body recycles certain amino acids. Many people with 5-oxoprolinase deficiency have no clear signs, but some develop seizures, low muscle tone, movement issues, or developmental delay in infancy or childhood. Features can range from mild to more serious, and the course is lifelong. Treatment focuses on managing seizures, supporting development, and nutrition with guidance from a metabolic specialist. Not everyone will have the same experience, and with care many people with 5-oxoprolinase deficiency can do well.
Overview
5-oxoprolinase deficiencySymptoms
Many people with 5-oxoprolinase deficiency have no clear features. When present, reported features include developmental delay, learning difficulties, low muscle tone, poor coordination, and seizures. Some also show behavioral challenges or short stature, often noticed in early childhood.
Outlook and prognosis
Many people with 5-oxoprolinase deficiency have mild or no day‑to‑day symptoms and lead typical lives, especially when episodes are recognized and managed early. Others may experience learning differences or metabolic flares that improve with supportive care. Regular follow‑up helps guide nutrition, medications, and safety planning.
Causes and risk factors
5-oxoprolinase deficiency results from pathogenic changes in the OPLAH gene, inherited in an autosomal recessive pattern. Risk increases when both parents are carriers, especially with consanguinity. Illness, fasting, and some medications may worsen symptoms but do not cause it.
Genetic influences
Genetics is central in 5-oxoprolinase deficiency, which results from pathogenic variants in the OPLAH gene. It’s typically inherited in an autosomal recessive pattern, so both copies need changes. Carrier parents have a 25% chance per pregnancy of an affected child.
Diagnosis
Doctors suspect it from clinical features and metabolic testing showing high 5‑oxoproline in urine or blood. Genetic tests confirming OPLAH variants establish the diagnosis. Enzyme studies, when available, can support the genetic diagnosis of 5‑oxoprolinase deficiency.
Treatment and drugs
Treatment for 5-oxoprolinase deficiency focuses on preventing and managing high anion gap metabolic acidosis and related symptoms. Care may include IV fluids, bicarbonate, electrolyte support, careful nutrition, and stopping triggers like certain medicines; genetics and metabolic teams guide follow-up. Regular monitoring helps adjust plans early during illness or stress.
Symptoms
5-oxoprolinase deficiency is a rare inherited condition. Some people have no clear problems, while others develop issues with development, movement, or learning in childhood; early features of 5-oxoprolinase deficiency may be subtle. Features vary from person to person and can change over time. Sometimes the condition is first suspected after urine or blood testing shows unusual acid levels, even when daily life seems mostly unaffected.
Many with 5-oxoprolinase deficiency feel well and meet milestones on time. The condition may be found only through lab testing done for another reason.
In 5-oxoprolinase deficiency, delays in rolling, sitting, or walking can appear in early childhood. Loved ones often notice the changes first.
In 5-oxoprolinase deficiency, first words may come later than expected and new words can build slowly. This can affect classroom learning and everyday conversations.
Muscles may feel looser or floppy, and babies can seem harder to pick up or position. Clinicians call this hypotonia, which means lower-than-typical muscle tone. Physical therapy often helps improve strength and control.
How people usually first notice 5-oxoprolinase deficiency?
Families rarely spot the first signs of 5-oxoprolinase deficiency on their own; it’s usually first noticed when a baby or young child has unexplained metabolic findings on blood or urine testing, sometimes after an illness triggers vomiting, poor feeding, or unusual tiredness. Doctors may pick it up through elevated pyroglutamic acid (5-oxoproline) on urine organic acid analysis, or during evaluation for developmental delays, seizures, or recurrent high–anion gap metabolic acidosis. In some, it’s found later in childhood or adulthood during workups for persistent metabolic acidosis or anemia, and genetic testing then confirms the diagnosis.
Types of 5-oxoprolinase deficiency
5-oxoprolinase deficiency is a rare inherited condition where a blocked step in a glutathione pathway can lead to buildup of certain acids and varied symptoms. Researchers describe a few clinical variants based on how the gene change affects enzyme activity and when signs first show up. Not everyone will experience every type. Here are the main variants people may read about when looking for types of 5-oxoprolinase deficiency.
Classic infantile-onset
Symptoms begin in the first months or years of life with feeding difficulty, slow weight gain, and developmental delay. Seizures and low muscle tone may occur, and urine testing can show elevated related acids. Early symptoms of 5-oxoprolinase deficiency often prompt metabolic evaluation.
Childhood-onset milder
Signs appear later in early childhood with learning challenges, attention concerns, or mild motor delays. Growth is usually closer to typical, and seizures are less common or absent.
Adolescent/adult attenuated
People may have few symptoms in daily life and are identified after urine organic acid testing for unrelated reasons. Some report headaches, fatigue, or mild cognitive concerns without clear neurological findings.
Severe neonatal form
Rarely, symptoms present shortly after birth with poor feeding, low muscle tone, and significant metabolic abnormalities. Intensive care may be needed, and seizures can be difficult to control.
Genotype–phenotype spectrum
Different OPLAH gene changes can leave varying amounts of enzyme activity, which helps explain the range from severe to very mild disease. Family members with the same variant can still have different symptom intensity.
What genetics can tell you about symptoms
Some people with OPLAH gene variants that severely reduce enzyme activity develop recurrent high anion gap metabolic acidosis, fatigue, vomiting, and failure to thrive, often starting in infancy. Milder OPLAH changes may cause intermittent episodes triggered by illness, with headaches, weakness, or confusion.
Causes and risk factors
Most cases are caused by inherited changes in the OPLAH gene that lower the 5-oxoprolinase enzyme.
It is autosomal recessive, so a child is affected when both parents are carriers.
Family history of the condition and parental relatedness can raise the chance of 5-oxoprolinase deficiency.
Illness, fasting, or high metabolic stress, and some medicines that deplete glutathione, like high-dose acetaminophen (paracetamol), can trigger early symptoms of 5-oxoprolinase deficiency or make them worse.
Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
5-oxoprolinase deficiency is rare, and evidence points to very few environmental or body-based factors that change the chance of it occurring. Awareness of both biological and environmental influences helps you feel prepared. Based on current research, environmental and biological risk factors for 5-oxoprolinase deficiency are limited, and no specific pregnancy exposures have been confirmed. Below is what studies have and haven’t linked so far.
No specific chemicals, pollutants, medications, or infections before or during pregnancy have been shown to increase the chance of 5-oxoprolinase deficiency. Published reports are rare and do not show a consistent exposure pattern.
Common maternal conditions such as diabetes, thyroid disease, or hypertension have not been associated with higher risk of 5-oxoprolinase deficiency. Available data do not support a consistent link.
Advanced maternal or paternal age does not appear to raise the likelihood of this condition. Studies to date have not shown an age-related pattern.
There is no known difference in risk between boys and girls. The condition is considered sex-neutral in occurrence.
Genetic risk factors
5-oxoprolinase deficiency stems from changes in a gene called OPLAH. Risk is not destiny—it varies widely between individuals. Most people develop the condition only when they inherit two faulty copies, one from each parent, which is an autosomal recessive pattern.
OPLAH gene changes: Harmful variants in the OPLAH gene directly cause 5-oxoprolinase deficiency. Some changes weaken enzyme function, while others stop it almost completely. This can influence how severe features are.
Autosomal recessive pattern: A child is affected only when two nonworking copies are inherited, one from each parent. Each pregnancy between the same parents has a 25% chance of an affected child.
Carrier parents: When both parents carry an OPLAH change, their children have a higher chance of the condition. Carriers are usually healthy and may never know they carry a change.
Sibling recurrence risk: If one child is diagnosed with 5-oxoprolinase deficiency, each full sibling has a 25% chance to also be affected. Brothers and sisters have a 50% chance to be carriers.
Consanguinity: Parents who are related by blood are more likely to share the same rare OPLAH change. This raises the chance of having an affected child.
Two-copy changes: People are affected if there is a change on both gene copies—either the same change on both or two different changes, one on each. This is why early symptoms of 5-oxoprolinase deficiency can appear in siblings even when parents feel well.
Lifestyle risk factors
This is a genetic/congenital condition; lifestyle habits do not cause it, but they can influence glutathione balance, 5-oxoproline buildup, and symptom flare-ups. Understanding how lifestyle affects 5-oxoprolinase deficiency can help reduce episodes of fatigue, metabolic stress, or acidosis risk. Changes should be individualized and made with your clinical team.
Frequent or high-dose acetaminophen can deplete glutathione and raise 5-oxoproline burden. Limiting or substituting it under medical guidance may reduce acidosis risk in 5-oxoprolinase deficiency.
Binge or chronic drinking lowers hepatic glutathione and can amplify 5-oxoproline accumulation. Cutting back may lessen fatigue and metabolic acidosis susceptibility.
Tobacco-related oxidative stress consumes glutathione, potentially worsening 5-oxoproline buildup. Quitting may improve antioxidant reserves and reduce symptom flare-ups.
Diets low in cysteine and methionine can limit glutathione synthesis, increasing reliance on the gamma‑glutamyl cycle and 5-oxoproline accumulation. Ensuring adequate quality protein may support better metabolic balance.
Risk prevention
5-oxoprolinase deficiency is a rare inherited condition, so you can’t prevent the condition itself, but you can lower the chance of complications and flare-ups. Prevention can mean both medical steps, like vaccines, and lifestyle steps, like exercise. For many, this means knowing triggers, having an illness plan, and staying in touch with a metabolic specialist. Families can also plan ahead with genetic counseling and testing when appropriate.
Learn how the condition runs in families and discuss carrier testing for partners or relatives. Options like prenatal or preimplantation testing may be available in future pregnancies.
Avoid high-dose acetaminophen (paracetamol) unless your clinician says it’s necessary, as it can strain glutathione pathways. Review all new prescriptions and over-the-counter drugs with your care team.
During fever, vomiting, or poor intake, increase fluids and carbohydrates and avoid prolonged fasting. Know when to seek urgent care for early symptoms of 5-oxoprolinase deficiency that worsen with illness, like unusual sleepiness, rapid breathing, or vomiting.
Eat regular meals with balanced carbohydrates and protein to reduce metabolic stress. Skip crash diets, prolonged fasting, or very high-protein regimens without medical guidance.
Transmission
5-oxoprolinase deficiency isn’t contagious; you can’t catch it from someone or pass it on through everyday contact. It is inherited in an autosomal recessive pattern, meaning a child develops 5-oxoprolinase deficiency only when both parents carry one nonworking copy of the same gene and each passes it on. When both parents are carriers, each pregnancy has a 25% chance the child will have the condition, a 50% chance the child will be a carrier like the parents, and a 25% chance the child will inherit two working copies. Genetic transmission of 5-oxoprolinase deficiency may occur without a known family history because carrier status is silent; very rarely, new genetic changes can contribute. Genetic counseling and carrier testing can help families understand how 5-oxoprolinase deficiency is inherited and what the risks mean for future pregnancies.
When to test your genes
Consider testing if you have unexplained high anion gap metabolic acidosis, recurrent 5-oxoprolinuria (pyroglutamic acid in urine), or a family history of 5-oxoprolinase deficiency. Testing is also reasonable before pregnancy or for newborns in affected families to guide care. Results can personalize monitoring, diet, and medication choices.
Diagnosis
5-oxoprolinase deficiency is usually identified when routine tests or symptoms raise suspicion, then confirmed with specialized lab and genetic tests. Signs can be subtle, and many people are diagnosed after urine testing shows a specific pattern. Genetic testing may be offered to clarify risk or guide treatment.
Doctors review growth, development, diet, and medications, and look for features that might point to a metabolic condition. Many living with 5-oxoprolinase deficiency have few specific signs, so a careful history often guides which tests come next.
A urine test can show high levels of 5‑oxoproline (also called pyroglutamic acid). This finding raises suspicion for disorders of the glutathione pathway, including 5-oxoprolinase deficiency.
Blood tests or untargeted metabolomics can reveal patterns consistent with a glutathione-cycle disruption. These results support the diagnosis of 5-oxoprolinase deficiency when paired with urine findings.
Clinicians check for other reasons 5‑oxoproline can rise, such as certain medicines (like acetaminophen/paracetamol), poor nutrition, or severe illness. Excluding these helps confirm a genetic rather than an acquired cause.
Stages of 5-oxoprolinase deficiency
5-oxoprolinase deficiency does not have defined progression stages. Symptoms, if present, vary widely and don’t follow a predictable path; many people are identified by lab findings rather than gradual change, and early symptoms of 5-oxoprolinase deficiency can be subtle or absent. Different tests may be suggested to help confirm the diagnosis, such as urine testing that shows 5-oxoproline and genetic testing of the OPLAH gene. Doctors may also look for related metabolic or neurologic issues and recheck labs over time to guide care.
Outlook and prognosis
Looking at the long-term picture can be helpful. Most people with 5-oxoprolinase deficiency have a stable course and a normal life span, especially when symptoms are mild. Day to day, this condition may cause fatigue, muscle aches, or headaches; some notice learning or attention challenges in childhood. Episodes of metabolic acidosis can occur, often triggered by illness, dehydration, or certain medicines like high-dose acetaminophen, but these events are usually manageable with prompt care.
The outlook is not the same for everyone, but most reported cases describe intermittent symptoms rather than constant problems. When metabolic crises do happen, hospital care may be needed for fluids and careful correction of acid levels; deaths are rare in published reports, and mortality seems low when treatment is available. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Avoiding triggers, staying well hydrated during infections, and reviewing medications with a clinician can lower the chance of flare-ups.
Over time, most people with 5-oxoprolinase deficiency can attend school, work, and family life with adjustments during sick days or periods of increased fatigue. Early symptoms of 5-oxoprolinase deficiency can be subtle, so tracking patterns—like headaches after viral illnesses or tummy upset after certain drugs—helps tailor care and prevent setbacks. Talk with your doctor about what your personal outlook might look like. Genetic testing can sometimes provide more insight into prognosis, particularly when combined with your health history and response to treatment.
Long-term effects
For most people, day-to-day life is unaffected, and the condition may only show up on lab tests done for another reason. Others may have developmental or neurologic features that continue from childhood into adulthood, such as learning differences or occasional seizures. Long-term effects vary widely, and many live in stable health for years. Some families first notice early symptoms of 5-oxoprolinase deficiency in childhood, while others never see clear health changes beyond an unusual lab result.
Many have lifelong high levels of 5‑oxoproline in urine without acid buildup or organ injury. This is often an isolated lab finding in 5‑oxoprolinase deficiency. Doctors may confirm it with metabolic testing.
Some have learning difficulties or intellectual disability that remain steady over time. School and work needs can vary from mild support to more structured help. Abilities may be uneven across subjects.
A minority develop seizures that can begin in childhood or adolescence. Patterns range from rare events to more frequent episodes. Many with 5‑oxoprolinase deficiency never develop seizures.
Some show mild clumsiness, tremor, or low muscle tone. Fine-motor tasks and balance can take extra effort. Walking and overall mobility are often preserved.
How is it to live with 5-oxoprolinase deficiency?
Living with 5-oxoprolinase deficiency can feel puzzling because symptoms vary widely; some people have no day-to-day issues, while others experience episodes of fatigue, muscle weakness, or developmental and learning challenges that may require school supports and regular medical follow-up. Daily life often centers on steady routines—balanced nutrition, staying well hydrated, taking prescribed supplements or medications if recommended, and watching for signs of metabolic stress during illness. Families and caregivers may notice they plan ahead a bit more—sharing care plans with schools, coordinating checkups, and having an action plan for sick days—yet most find a rhythm that keeps life predictable and active. With good care and communication, many build a supportive circle that reduces worry and helps everyone feel confident about recognizing and managing flare-ups.
Treatment and drugs
Treatment for 5-oxoprolinase deficiency focuses on easing symptoms, preventing complications, and supporting nutrition and growth, since there’s no single curative therapy yet. Supportive care can make a real difference in how you feel day to day, which may include a balanced, protein-appropriate diet designed by a metabolic dietitian, careful hydration, and supplements if your team identifies specific vitamin or mineral gaps. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as medicines to manage seizures if they occur, therapies for developmental delays, and monitoring for metabolic acidosis with treatment when needed. Because responses vary, your doctor can help weigh the pros and cons of each option and adjust the plan over time, including reviewing any medications that might strain the body’s detox pathways. Ask your doctor about the best starting point for you, and consider periodic follow-up with a metabolic specialist as research on 5-oxoprolinase deficiency continues to evolve.
Non-drug treatment
Day to day, most people focus on steady routines and avoiding triggers rather than chasing new treatments. For some, especially those with early symptoms of 5-oxoprolinase deficiency, the goal is to support energy, growth, and learning while keeping lab values stable. Non-drug treatments often lay the foundation for long-term health alongside any medical care your team recommends. Plans vary by age and how the condition shows up, so your care team will tailor steps to your needs.
Regular meals and good fluid intake help maintain energy and reduce stress on the body. A dietitian familiar with metabolic conditions can guide a balanced protein plan and snacks to avoid long fasting.
Scheduled check-ins with a metabolic clinic can track growth, development, and lab markers like urine organic acids. Catching small changes early can prevent bigger problems.
Early intervention—such as physical, occupational, or speech therapy—can support movement, feeding, and communication if delays appear. Starting sooner often leads to better skills over time.
Some clinicians advise limiting acetaminophen (paracetamol) and reviewing antibiotics or other drugs that may strain glutathione balance. A pharmacist can help check current medicines and safer alternatives.
Your genes may have an impact on how drugs work for you
Even in a rare condition like 5‑oxoprolinase deficiency, the way your body handles medicines can vary based on genes that control drug breakdown and transport. Pharmacogenetic testing may guide dosing or drug choice to reduce side effects and improve benefit.
Pharmacological treatments
There is no specific enzyme-replacement or disease‑modifying drug for 5-oxoprolinase deficiency. Care focuses on preventing and treating metabolic acidosis and managing features like seizures if they occur. Not everyone responds to the same medication in the same way. Recognizing early symptoms of 5-oxoprolinase deficiency during an acidosis flare—like unusual tiredness, nausea, or fast breathing—helps doctors choose timely medicines.
This medicine can replenish glutathione and is sometimes used during acute pyroglutamic (5‑oxoproline) acidosis. It may be given by mouth or IV under hospital monitoring. Benefit is greatest when acetaminophen exposure or oxidative stress is a trigger.
Given by mouth or IV to correct metabolic acidosis during flares. Doctors track blood gases and electrolytes to guide dosing. Overcorrection can cause fluid or sodium shifts, so monitoring is important.
If seizures occur, levetiracetam is commonly used to reduce events. Choice of anti-seizure drug depends on age, other conditions, and drug interactions. Regular follow-up helps adjust the dose and watch side effects.
Glucose-containing fluids support metabolism and help clear organic acids during acute illness. Hospitals tailor the rate and composition to labs and hydration status. This is usually short-term support during a flare.
Genetic influences
5-oxoprolinase deficiency happens when both copies of a gene called OPLAH have changes that reduce the enzyme’s activity; this is inherited in an autosomal recessive pattern. Parents are typically healthy carriers, and when both carry an OPLAH change, each pregnancy has a 25% (1 in 4) chance of a child inheriting the condition. A “carrier” means you hold the gene change but may not show symptoms. The OPLAH gene helps the body recycle a small molecule in a pathway that protects cells; when it doesn’t work well, 5-oxoproline can build up, sometimes picked up on urine testing even in people who feel well. Severity is variable—many living with 5-oxoprolinase deficiency have few or no symptoms, while others may have nonspecific issues that a clinician evaluates in context. Genetic testing for 5-oxoprolinase deficiency can confirm the diagnosis, inform family planning, and help identify at-risk relatives; a genetics professional can walk you through options.
Is 5-oxoprolinase deficiency genetic?
Genetics is central in 5-oxoprolinase deficiency, which results from pathogenic variants in the OPLAH gene. It’s typically inherited in an autosomal recessive pattern, so both copies need changes. Carrier parents have a 25% chance per pregnancy of an affected child.
Pharmacogenetics—how genetics influence drug effects
Because the enzyme affected in 5-oxoprolinase deficiency is part of the body’s glutathione recycling pathway, certain medicines that stress this system can raise the risk of acid buildup and make someone feel unwell. Doctors often use extra caution with acetaminophen (paracetamol) and some penicillin-type antibiotics, limiting dose, avoiding long courses, or choosing alternatives. If these drugs are needed, teams may monitor blood acid levels and kidney function and consider glutathione-supporting treatments such as N-acetylcysteine (NAC) when appropriate. Genetics is only one factor, so nutrition, infection, pregnancy, and liver or kidney problems can also change how risky a medicine is. The exact gene change can differ between people, so medication choices and dosing are individualized and may be adjusted over time. For many, the safest plan is a medication list reviewed by a metabolic or genetics team, with clear guidance for medication safety in 5-oxoprolinase deficiency during pain, fever, and infections.
Interactions with other conditions
Intercurrent infections, fasting, or heavy use of acetaminophen (paracetamol) can trigger or worsen high–anion gap metabolic acidosis in people with 5-oxoprolinase deficiency. When kidney or liver disease is also present, a condition may “exacerbate” (make worse) symptoms of another, since reduced clearance or low glutathione stores let 5‑oxoproline build up more quickly. Sepsis, malnutrition, and pregnancy are additional situations where glutathione tends to drop, so acidosis linked to 5‑oxoproline can be more likely or more severe. If diabetes, asthma, or chronic pain leads to frequent acetaminophen use, it’s worth discussing alternatives, because long-term exposure is a recognized trigger for pyroglutamic (5‑oxoproline) acidosis. Early symptoms of 5-oxoprolinase deficiency—such as tiredness, nausea, or fast breathing from acidosis—can blend into another illness, which can make it harder to sort out what’s driving what. People with chronic kidney disease may need closer monitoring during infections or after surgery, when body stress rises and acid levels can change quickly.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who tired easily, had repeated illnesses, or weren’t growing as expected, with no clear cause. Families and communities once noticed patterns across siblings or cousins, hinting that something inherited might be involved. Looking back helps explain why a rare metabolic problem like 5-oxoprolinase deficiency took time to recognize: the signs were subtle, blood tests were limited, and the condition can look like many other childhood issues.
First described in the medical literature as a cause of unusual organic acids in urine, 5-oxoprolinase deficiency came into view only after clinicians began using specialized urine and blood testing in the late 20th century. Early reports focused on a handful of children with developmental delays, muscle weakness, or repeated infections, and lab findings that didn’t match better-known disorders. Initially understood only through symptoms, later case studies linked these findings to a problem in the body’s handling of glutathione, a small molecule that helps protect cells from stress.
As medical science evolved, researchers mapped out the steps of the gamma‑glutamyl cycle, the pathway that builds and recycles glutathione. In that map, 5‑oxoprolinase acts like a key connector. When the enzyme is missing or works poorly, certain byproducts build up, which doctors can detect in urine organic acid profiles. In recent decades, awareness has grown as more centers adopted metabolic screening, allowing clinicians to recognize the pattern sooner and distinguish 5-oxoprolinase deficiency from similar conditions.
Advances in genetics then confirmed the cause. Sequencing studies identified changes in the OPLAH gene that impair 5‑oxoprolinase function. Family reports showed an autosomal recessive pattern—parents who are healthy carriers can have more than one child with the condition. With each decade, the number of documented cases increased, not because the condition suddenly became common, but because testing improved and clinicians knew what to look for.
Over time, descriptions became more nuanced. Some people with 5-oxoprolinase deficiency have few or no symptoms and are found through family testing or research studies, while others have more noticeable issues in infancy or childhood. This variability, seen in case reports from different countries, helped clarify that the condition spans a spectrum. It also explained why early descriptions seemed conflicting.
Today, the history of 5-oxoprolinase deficiency reflects a broader shift in rare disease medicine: from puzzling symptoms and isolated reports to clear biochemical testing and genetic confirmation. Knowing the condition’s history reminds us why careful lab work, family histories, and modern sequencing all matter when evaluating early symptoms of 5-oxoprolinase deficiency.